Clinical Trial: Hydrothermal Ablation in Recurrent and Chronic Symptomatic Bursitis

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Hydrothermal Ablation in Recurrent and Chronic Symptomatic Bursitis With the Ablaflex Device: An Open, Exploratory, 6-month Dose-tolerance and Dose Response Study

Brief Summary: The overall objective of this trial is to explore the dose-tolerance (safety) and dose-response (efficacy) of single 3-minute intra-bursal perfusions of a physiological saline solution at increasing temperatures.